Home/Evommune/Kyle Carver, M.B.A., C.P.A.
KC

Kyle Carver, M.B.A., C.P.A.

Chief Financial Officer

Evommune

Evommune Pipeline

DrugIndicationPhase
EVO756Chronic Spontaneous UrticariaPhase 2b
EVO301Atopic DermatitisPhase 2